Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-07

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved the original approval application for a generic carbidopa/levodopa product from ScieGen Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)